ISRCTN96218197已完成未知
Early goal directed therapy for adult meningitis in Malawi
iverpool School of Tropical Medicine (UK)0 个研究点目标入组 200 人开始时间: 2011年11月17日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Screening inclusion criteria
- •1. 1. All adults > 12 years presenting to the adult emergency trauma centre with fever plus one of headache/convulsions/confusion/neck stiffness (Note: In Malawi the cut off for paediatric medicine is <12 years and all admissions over this age are referred to the adult service)
- •2. Final inclusion criteria
- •2.1. Cerebrospinal fluid (CSF) white cell count of >50 cells/mm2, irrespective of human immunodeficiency virus (HIV) status, or visible bacteria in the counting chamber
排除标准
- •1. Screening exclusion criteria
- •1.1. Known terminal disease
- •1.2. Head injury
- •1.3. Proven cerebral malaria
- •2. Final exclusion criteria
- •2.1. CSF culture, antigen test or stain for fungal or mycobacterial organisms, or CSF <100 cells/mm3 HIV negative or CSF <5 cells/mm3 HIV positive, or a CSF WCC <50% neutrophils
研究者
相似试验
已完成
不适用
Clinical care bundles for adult meningitis in MalawiBacterial meningitisPACTR201111000338157iverpool School of Tropical Medicine200
进行中（未招募）
1 期
Meningococcal B Booster Vaccine in Young PeopleMeningococcus group B disease, which can cause a variety of symptoms. The most serious of these are meningitis, and septicaemia (also known as blood poisoning).EUCTR2017-004732-11-GBniversity of Oxford117
Unknown
不适用
Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and TreatmentMeningoencephalitisNext-Generation SequencingPolymerase Chain ReactionMeningitisEncephalitisNCT04946682Wen-hong Zhang484
已完成
不适用
Meningococcal B Booster Vaccine in Young PeopleSpecialty: Infection, Primary sub-specialty: VaccinesUKCRC code/ Disease: Inflammatory and Immune System/ Certain disorders involving the immune mechanismInfections and InfestationsMeningococcal infection, unspecifiedISRCTN16774163niversity of Oxford72
已完成
2 期
Study in Adolescents/Adults to Evaluate Non-inferiority&Persistence up to 5 Years of GSK Bio MenACWY Conjugate VaccineInfections, MeningococcalNCT00356369GlaxoSmithKline500